MOLECULES-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=2149996, encodeId=00be2149996b3, content=四天前发了邮件给编辑部，到现在都没回，我太难了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cb368660953, createdName=ms9000001976206462, createdTime=Wed Jul 26 20:27:40 CST 2023, time=2023-07-26, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1240251, encodeId=192c12402515c, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：分享一下经验，之前接受到杂志的约稿邮件，然后整理数据将文章投上去，投的是杂志特刊，做的是药物治疗疾病的研究和机制探讨，特别要表扬的是编辑，超级超级超级。。。Nice，真的是有问必回，而且特别高效。送了3个审稿人，然后经历过一次小修（5天时间要求修回），收到接收函的第二天proof和invoice就来了，proof要求24小时内提交，付款要求5天内完成。从投到接收不到1个月。因为是约稿，版面费还有优惠，所以该杂志值得投稿，良心杂志。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=8c811928827, createdName=1e0c52fcm39(暂无匿称), createdTime=Mon Aug 22 11:15:01 CST 2022, time=2022-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2117818, encodeId=e1e5211e818bf, content=伦理要求上传Patient Consent Form for Articles Containing Patient Details and/or Images。能否使用representative，Relationship of representative to patient这一部分怎么填啊？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a7475559954, createdName=ms1000001854041919, createdTime=Sun Mar 05 23:07:34 CST 2023, time=2023-03-05, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=915861, encodeId=048e9158618d, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：这杂志一审居然4个审稿人，3小修一拒，给了个大修！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=129, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/07/03/a49c0c976fe7f81b1448833c8538aa24.jpg, createdBy=cb9a1630518, createdName=Rtase, createdTime=Tue Jan 12 11:40:34 CST 2021, time=2021-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2098959, encodeId=afd520989595f, content=WB需要全膜带Marker的原始数据吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=2f0d2095817, createdName=含, createdTime=Mon Nov 07 13:16:41 CST 2022, time=2022-11-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1240378, encodeId=c9df12403e837, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：单体;动物疾病模型 经验分享：两个审稿人均要求疯狂补实验，要求很苛刻，大修两次，终于接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=01c92285047, createdName=361152897, createdTime=Mon Aug 22 22:27:34 CST 2022, time=2022-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2092279, encodeId=c6cd20922e9ed, content=审稿速度:1.0 经验分享：确实审稿特别快，两个星期就有相应的返修意见，历经2个星期返修，一天小修，就接受了，历经一个月，编辑对很多文章的逻辑问题还有其他小问题，都会提到，非常负责，非常感谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=93c45646864, createdName=ms8000000222715123, createdTime=Fri Oct 07 14:47:47 CST 2022, time=2022-10-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1232693, encodeId=05401232693bb, content=想问下拒收医院投稿是所有作者里都不能有作者单位是医院的吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=097b5528718, createdName=ms1000000533864290, createdTime=Fri Jul 15 22:23:33 CST 2022, time=2022-07-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1200156, encodeId=45aa120015642, content=偏重的研究方向：药理;中药 经验分享：想问一下我的under review一个月了，还没消息。不是说很快嘛？着急。可以催稿吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bc165513547, createdName=ms6000001633558853, createdTime=Mon Mar 07 09:16:08 CST 2022, time=2022-03-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=581730, encodeId=bb33581e302a, content=请问需要机构邮箱吗？自己的邮箱不行吗？130xyvn1159(暂无昵称) 2019-05-14 17:41:00 发表: 分享一下经验，效率非常高的杂志，我做的中药单体。4月2日投稿，4月15日编辑给的大修意见，限时10天。两个审稿人都非常负责，非常专业，给提的问题和建议也非常多，写了15页的response，最后一天修回。4月29日通知小修，5月3日修回。5月4日再次小修。5月8日正式录用。着急毕业的小伙伴们的不错选择。总体感觉高效、负责而且编辑特别友好，有问题可以随时邮件沟通。, beContent=130xyvn1159(暂无昵称) 2019-05-14 17:41:00 发表: 分享一下经验，效率非常高的杂志，我做的中药单体。4月2日投稿，4月15日编辑给的大修意见，限时10天。两个审稿人都非常负责，非常专业，给提的问题和建议也非常多，写了15页的response，最后一天修回。4月29日通知小修，5月3日修回。5月4日再次小修。5月8日正式录用。着急毕业的小伙伴们的不错选择。总体感觉高效、负责而且编辑特别友好，有问题可以随时邮件沟通。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=132, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/4NXDp7dcypiciaGCGMHhr89HtM35HDYiaaFxvhVe8OBZhvT0shhzj9TiczQwEA8xibW2Elb4XQciaB3hKL7aHww8g90w/0, createdBy=5af82170565, createdName=绿蚁红泥, createdTime=Wed Dec 18 00:00:00 CST 2019, time=2019-12-18, status=1, ipAttribution=)]

2023-07-26 ms9000001976206462 来自广东省

四天前发了邮件给编辑部，到现在都没回，我太难了

29 0

[GetPortalCommentsPageByObjectIdResponse(id=2149996, encodeId=00be2149996b3, content=四天前发了邮件给编辑部，到现在都没回，我太难了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cb368660953, createdName=ms9000001976206462, createdTime=Wed Jul 26 20:27:40 CST 2023, time=2023-07-26, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1240251, encodeId=192c12402515c, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：分享一下经验，之前接受到杂志的约稿邮件，然后整理数据将文章投上去，投的是杂志特刊，做的是药物治疗疾病的研究和机制探讨，特别要表扬的是编辑，超级超级超级。。。Nice，真的是有问必回，而且特别高效。送了3个审稿人，然后经历过一次小修（5天时间要求修回），收到接收函的第二天proof和invoice就来了，proof要求24小时内提交，付款要求5天内完成。从投到接收不到1个月。因为是约稿，版面费还有优惠，所以该杂志值得投稿，良心杂志。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=8c811928827, createdName=1e0c52fcm39(暂无匿称), createdTime=Mon Aug 22 11:15:01 CST 2022, time=2022-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2117818, encodeId=e1e5211e818bf, content=伦理要求上传Patient Consent Form for Articles Containing Patient Details and/or Images。能否使用representative，Relationship of representative to patient这一部分怎么填啊？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a7475559954, createdName=ms1000001854041919, createdTime=Sun Mar 05 23:07:34 CST 2023, time=2023-03-05, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=915861, encodeId=048e9158618d, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：这杂志一审居然4个审稿人，3小修一拒，给了个大修！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=129, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/07/03/a49c0c976fe7f81b1448833c8538aa24.jpg, createdBy=cb9a1630518, createdName=Rtase, createdTime=Tue Jan 12 11:40:34 CST 2021, time=2021-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2098959, encodeId=afd520989595f, content=WB需要全膜带Marker的原始数据吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=2f0d2095817, createdName=含, createdTime=Mon Nov 07 13:16:41 CST 2022, time=2022-11-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1240378, encodeId=c9df12403e837, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：单体;动物疾病模型 经验分享：两个审稿人均要求疯狂补实验，要求很苛刻，大修两次，终于接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=01c92285047, createdName=361152897, createdTime=Mon Aug 22 22:27:34 CST 2022, time=2022-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2092279, encodeId=c6cd20922e9ed, content=审稿速度:1.0 经验分享：确实审稿特别快，两个星期就有相应的返修意见，历经2个星期返修，一天小修，就接受了，历经一个月，编辑对很多文章的逻辑问题还有其他小问题，都会提到，非常负责，非常感谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=93c45646864, createdName=ms8000000222715123, createdTime=Fri Oct 07 14:47:47 CST 2022, time=2022-10-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1232693, encodeId=05401232693bb, content=想问下拒收医院投稿是所有作者里都不能有作者单位是医院的吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=097b5528718, createdName=ms1000000533864290, createdTime=Fri Jul 15 22:23:33 CST 2022, time=2022-07-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1200156, encodeId=45aa120015642, content=偏重的研究方向：药理;中药 经验分享：想问一下我的under review一个月了，还没消息。不是说很快嘛？着急。可以催稿吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bc165513547, createdName=ms6000001633558853, createdTime=Mon Mar 07 09:16:08 CST 2022, time=2022-03-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=581730, encodeId=bb33581e302a, content=请问需要机构邮箱吗？自己的邮箱不行吗？130xyvn1159(暂无昵称) 2019-05-14 17:41:00 发表: 分享一下经验，效率非常高的杂志，我做的中药单体。4月2日投稿，4月15日编辑给的大修意见，限时10天。两个审稿人都非常负责，非常专业，给提的问题和建议也非常多，写了15页的response，最后一天修回。4月29日通知小修，5月3日修回。5月4日再次小修。5月8日正式录用。着急毕业的小伙伴们的不错选择。总体感觉高效、负责而且编辑特别友好，有问题可以随时邮件沟通。, beContent=130xyvn1159(暂无昵称) 2019-05-14 17:41:00 发表: 分享一下经验，效率非常高的杂志，我做的中药单体。4月2日投稿，4月15日编辑给的大修意见，限时10天。两个审稿人都非常负责，非常专业，给提的问题和建议也非常多，写了15页的response，最后一天修回。4月29日通知小修，5月3日修回。5月4日再次小修。5月8日正式录用。着急毕业的小伙伴们的不错选择。总体感觉高效、负责而且编辑特别友好，有问题可以随时邮件沟通。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=132, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/4NXDp7dcypiciaGCGMHhr89HtM35HDYiaaFxvhVe8OBZhvT0shhzj9TiczQwEA8xibW2Elb4XQciaB3hKL7aHww8g90w/0, createdBy=5af82170565, createdName=绿蚁红泥, createdTime=Wed Dec 18 00:00:00 CST 2019, time=2019-12-18, status=1, ipAttribution=)]

2022-08-22 1e0c52fcm39(暂无匿称)

审稿速度:1.0 | 投稿命中率:75.0
经验分享：分享一下经验，之前接受到杂志的约稿邮件，然后整理数据将文章投上去，投的是杂志特刊，做的是药物治疗疾病的研究和机制探讨，特别要表扬的是编辑，超级超级超级。。。Nice，真的是有问必回，而且特别高效。送了3个审稿人，然后经历过一次小修（5天时间要求修回），收到接收函的第二天proof和invoice就来了，proof要求24小时内提交，付款要求5天内完成。从投到接收不到1个月。因为是约稿，版面费还有优惠，所以该杂志值得投稿，良心杂志。

62 4

展开4条回复

[GetPortalCommentsPageByObjectIdResponse(id=2149996, encodeId=00be2149996b3, content=四天前发了邮件给编辑部，到现在都没回，我太难了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cb368660953, createdName=ms9000001976206462, createdTime=Wed Jul 26 20:27:40 CST 2023, time=2023-07-26, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1240251, encodeId=192c12402515c, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：分享一下经验，之前接受到杂志的约稿邮件，然后整理数据将文章投上去，投的是杂志特刊，做的是药物治疗疾病的研究和机制探讨，特别要表扬的是编辑，超级超级超级。。。Nice，真的是有问必回，而且特别高效。送了3个审稿人，然后经历过一次小修（5天时间要求修回），收到接收函的第二天proof和invoice就来了，proof要求24小时内提交，付款要求5天内完成。从投到接收不到1个月。因为是约稿，版面费还有优惠，所以该杂志值得投稿，良心杂志。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=8c811928827, createdName=1e0c52fcm39(暂无匿称), createdTime=Mon Aug 22 11:15:01 CST 2022, time=2022-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2117818, encodeId=e1e5211e818bf, content=伦理要求上传Patient Consent Form for Articles Containing Patient Details and/or Images。能否使用representative，Relationship of representative to patient这一部分怎么填啊？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a7475559954, createdName=ms1000001854041919, createdTime=Sun Mar 05 23:07:34 CST 2023, time=2023-03-05, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=915861, encodeId=048e9158618d, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：这杂志一审居然4个审稿人，3小修一拒，给了个大修！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=129, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/07/03/a49c0c976fe7f81b1448833c8538aa24.jpg, createdBy=cb9a1630518, createdName=Rtase, createdTime=Tue Jan 12 11:40:34 CST 2021, time=2021-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2098959, encodeId=afd520989595f, content=WB需要全膜带Marker的原始数据吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=2f0d2095817, createdName=含, createdTime=Mon Nov 07 13:16:41 CST 2022, time=2022-11-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1240378, encodeId=c9df12403e837, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：单体;动物疾病模型 经验分享：两个审稿人均要求疯狂补实验，要求很苛刻，大修两次，终于接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=01c92285047, createdName=361152897, createdTime=Mon Aug 22 22:27:34 CST 2022, time=2022-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2092279, encodeId=c6cd20922e9ed, content=审稿速度:1.0 经验分享：确实审稿特别快，两个星期就有相应的返修意见，历经2个星期返修，一天小修，就接受了，历经一个月，编辑对很多文章的逻辑问题还有其他小问题，都会提到，非常负责，非常感谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=93c45646864, createdName=ms8000000222715123, createdTime=Fri Oct 07 14:47:47 CST 2022, time=2022-10-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1232693, encodeId=05401232693bb, content=想问下拒收医院投稿是所有作者里都不能有作者单位是医院的吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=097b5528718, createdName=ms1000000533864290, createdTime=Fri Jul 15 22:23:33 CST 2022, time=2022-07-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1200156, encodeId=45aa120015642, content=偏重的研究方向：药理;中药 经验分享：想问一下我的under review一个月了，还没消息。不是说很快嘛？着急。可以催稿吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bc165513547, createdName=ms6000001633558853, createdTime=Mon Mar 07 09:16:08 CST 2022, time=2022-03-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=581730, encodeId=bb33581e302a, content=请问需要机构邮箱吗？自己的邮箱不行吗？130xyvn1159(暂无昵称) 2019-05-14 17:41:00 发表: 分享一下经验，效率非常高的杂志，我做的中药单体。4月2日投稿，4月15日编辑给的大修意见，限时10天。两个审稿人都非常负责，非常专业，给提的问题和建议也非常多，写了15页的response，最后一天修回。4月29日通知小修，5月3日修回。5月4日再次小修。5月8日正式录用。着急毕业的小伙伴们的不错选择。总体感觉高效、负责而且编辑特别友好，有问题可以随时邮件沟通。, beContent=130xyvn1159(暂无昵称) 2019-05-14 17:41:00 发表: 分享一下经验，效率非常高的杂志，我做的中药单体。4月2日投稿，4月15日编辑给的大修意见，限时10天。两个审稿人都非常负责，非常专业，给提的问题和建议也非常多，写了15页的response，最后一天修回。4月29日通知小修，5月3日修回。5月4日再次小修。5月8日正式录用。着急毕业的小伙伴们的不错选择。总体感觉高效、负责而且编辑特别友好，有问题可以随时邮件沟通。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=132, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/4NXDp7dcypiciaGCGMHhr89HtM35HDYiaaFxvhVe8OBZhvT0shhzj9TiczQwEA8xibW2Elb4XQciaB3hKL7aHww8g90w/0, createdBy=5af82170565, createdName=绿蚁红泥, createdTime=Wed Dec 18 00:00:00 CST 2019, time=2019-12-18, status=1, ipAttribution=)]

2023-03-05 ms1000001854041919 来自北京

伦理要求上传Patient Consent Form for Articles Containing Patient Details and/or Images。能否使用representative，Relationship of representative to patient这一部分怎么填啊？

35 0

[GetPortalCommentsPageByObjectIdResponse(id=2149996, encodeId=00be2149996b3, content=四天前发了邮件给编辑部，到现在都没回，我太难了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cb368660953, createdName=ms9000001976206462, createdTime=Wed Jul 26 20:27:40 CST 2023, time=2023-07-26, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1240251, encodeId=192c12402515c, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：分享一下经验，之前接受到杂志的约稿邮件，然后整理数据将文章投上去，投的是杂志特刊，做的是药物治疗疾病的研究和机制探讨，特别要表扬的是编辑，超级超级超级。。。Nice，真的是有问必回，而且特别高效。送了3个审稿人，然后经历过一次小修（5天时间要求修回），收到接收函的第二天proof和invoice就来了，proof要求24小时内提交，付款要求5天内完成。从投到接收不到1个月。因为是约稿，版面费还有优惠，所以该杂志值得投稿，良心杂志。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=8c811928827, createdName=1e0c52fcm39(暂无匿称), createdTime=Mon Aug 22 11:15:01 CST 2022, time=2022-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2117818, encodeId=e1e5211e818bf, content=伦理要求上传Patient Consent Form for Articles Containing Patient Details and/or Images。能否使用representative，Relationship of representative to patient这一部分怎么填啊？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a7475559954, createdName=ms1000001854041919, createdTime=Sun Mar 05 23:07:34 CST 2023, time=2023-03-05, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=915861, encodeId=048e9158618d, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：这杂志一审居然4个审稿人，3小修一拒，给了个大修！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=129, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/07/03/a49c0c976fe7f81b1448833c8538aa24.jpg, createdBy=cb9a1630518, createdName=Rtase, createdTime=Tue Jan 12 11:40:34 CST 2021, time=2021-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2098959, encodeId=afd520989595f, content=WB需要全膜带Marker的原始数据吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=2f0d2095817, createdName=含, createdTime=Mon Nov 07 13:16:41 CST 2022, time=2022-11-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1240378, encodeId=c9df12403e837, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：单体;动物疾病模型 经验分享：两个审稿人均要求疯狂补实验，要求很苛刻，大修两次，终于接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=01c92285047, createdName=361152897, createdTime=Mon Aug 22 22:27:34 CST 2022, time=2022-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2092279, encodeId=c6cd20922e9ed, content=审稿速度:1.0 经验分享：确实审稿特别快，两个星期就有相应的返修意见，历经2个星期返修，一天小修，就接受了，历经一个月，编辑对很多文章的逻辑问题还有其他小问题，都会提到，非常负责，非常感谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=93c45646864, createdName=ms8000000222715123, createdTime=Fri Oct 07 14:47:47 CST 2022, time=2022-10-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1232693, encodeId=05401232693bb, content=想问下拒收医院投稿是所有作者里都不能有作者单位是医院的吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=097b5528718, createdName=ms1000000533864290, createdTime=Fri Jul 15 22:23:33 CST 2022, time=2022-07-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1200156, encodeId=45aa120015642, content=偏重的研究方向：药理;中药 经验分享：想问一下我的under review一个月了，还没消息。不是说很快嘛？着急。可以催稿吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bc165513547, createdName=ms6000001633558853, createdTime=Mon Mar 07 09:16:08 CST 2022, time=2022-03-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=581730, encodeId=bb33581e302a, content=请问需要机构邮箱吗？自己的邮箱不行吗？130xyvn1159(暂无昵称) 2019-05-14 17:41:00 发表: 分享一下经验，效率非常高的杂志，我做的中药单体。4月2日投稿，4月15日编辑给的大修意见，限时10天。两个审稿人都非常负责，非常专业，给提的问题和建议也非常多，写了15页的response，最后一天修回。4月29日通知小修，5月3日修回。5月4日再次小修。5月8日正式录用。着急毕业的小伙伴们的不错选择。总体感觉高效、负责而且编辑特别友好，有问题可以随时邮件沟通。, beContent=130xyvn1159(暂无昵称) 2019-05-14 17:41:00 发表: 分享一下经验，效率非常高的杂志，我做的中药单体。4月2日投稿，4月15日编辑给的大修意见，限时10天。两个审稿人都非常负责，非常专业，给提的问题和建议也非常多，写了15页的response，最后一天修回。4月29日通知小修，5月3日修回。5月4日再次小修。5月8日正式录用。着急毕业的小伙伴们的不错选择。总体感觉高效、负责而且编辑特别友好，有问题可以随时邮件沟通。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=132, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/4NXDp7dcypiciaGCGMHhr89HtM35HDYiaaFxvhVe8OBZhvT0shhzj9TiczQwEA8xibW2Elb4XQciaB3hKL7aHww8g90w/0, createdBy=5af82170565, createdName=绿蚁红泥, createdTime=Wed Dec 18 00:00:00 CST 2019, time=2019-12-18, status=1, ipAttribution=)]

2021-01-12 Rtase

审稿速度:1.0 | 投稿命中率:50.0
经验分享：这杂志一审居然4个审稿人，3小修一拒，给了个大修！

129 10

展开10条回复

[GetPortalCommentsPageByObjectIdResponse(id=2149996, encodeId=00be2149996b3, content=四天前发了邮件给编辑部，到现在都没回，我太难了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cb368660953, createdName=ms9000001976206462, createdTime=Wed Jul 26 20:27:40 CST 2023, time=2023-07-26, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1240251, encodeId=192c12402515c, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：分享一下经验，之前接受到杂志的约稿邮件，然后整理数据将文章投上去，投的是杂志特刊，做的是药物治疗疾病的研究和机制探讨，特别要表扬的是编辑，超级超级超级。。。Nice，真的是有问必回，而且特别高效。送了3个审稿人，然后经历过一次小修（5天时间要求修回），收到接收函的第二天proof和invoice就来了，proof要求24小时内提交，付款要求5天内完成。从投到接收不到1个月。因为是约稿，版面费还有优惠，所以该杂志值得投稿，良心杂志。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=8c811928827, createdName=1e0c52fcm39(暂无匿称), createdTime=Mon Aug 22 11:15:01 CST 2022, time=2022-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2117818, encodeId=e1e5211e818bf, content=伦理要求上传Patient Consent Form for Articles Containing Patient Details and/or Images。能否使用representative，Relationship of representative to patient这一部分怎么填啊？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a7475559954, createdName=ms1000001854041919, createdTime=Sun Mar 05 23:07:34 CST 2023, time=2023-03-05, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=915861, encodeId=048e9158618d, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：这杂志一审居然4个审稿人，3小修一拒，给了个大修！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=129, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/07/03/a49c0c976fe7f81b1448833c8538aa24.jpg, createdBy=cb9a1630518, createdName=Rtase, createdTime=Tue Jan 12 11:40:34 CST 2021, time=2021-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2098959, encodeId=afd520989595f, content=WB需要全膜带Marker的原始数据吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=2f0d2095817, createdName=含, createdTime=Mon Nov 07 13:16:41 CST 2022, time=2022-11-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1240378, encodeId=c9df12403e837, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：单体;动物疾病模型 经验分享：两个审稿人均要求疯狂补实验，要求很苛刻，大修两次，终于接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=01c92285047, createdName=361152897, createdTime=Mon Aug 22 22:27:34 CST 2022, time=2022-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2092279, encodeId=c6cd20922e9ed, content=审稿速度:1.0 经验分享：确实审稿特别快，两个星期就有相应的返修意见，历经2个星期返修，一天小修，就接受了，历经一个月，编辑对很多文章的逻辑问题还有其他小问题，都会提到，非常负责，非常感谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=93c45646864, createdName=ms8000000222715123, createdTime=Fri Oct 07 14:47:47 CST 2022, time=2022-10-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1232693, encodeId=05401232693bb, content=想问下拒收医院投稿是所有作者里都不能有作者单位是医院的吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=097b5528718, createdName=ms1000000533864290, createdTime=Fri Jul 15 22:23:33 CST 2022, time=2022-07-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1200156, encodeId=45aa120015642, content=偏重的研究方向：药理;中药 经验分享：想问一下我的under review一个月了，还没消息。不是说很快嘛？着急。可以催稿吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bc165513547, createdName=ms6000001633558853, createdTime=Mon Mar 07 09:16:08 CST 2022, time=2022-03-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=581730, encodeId=bb33581e302a, content=请问需要机构邮箱吗？自己的邮箱不行吗？130xyvn1159(暂无昵称) 2019-05-14 17:41:00 发表: 分享一下经验，效率非常高的杂志，我做的中药单体。4月2日投稿，4月15日编辑给的大修意见，限时10天。两个审稿人都非常负责，非常专业，给提的问题和建议也非常多，写了15页的response，最后一天修回。4月29日通知小修，5月3日修回。5月4日再次小修。5月8日正式录用。着急毕业的小伙伴们的不错选择。总体感觉高效、负责而且编辑特别友好，有问题可以随时邮件沟通。, beContent=130xyvn1159(暂无昵称) 2019-05-14 17:41:00 发表: 分享一下经验，效率非常高的杂志，我做的中药单体。4月2日投稿，4月15日编辑给的大修意见，限时10天。两个审稿人都非常负责，非常专业，给提的问题和建议也非常多，写了15页的response，最后一天修回。4月29日通知小修，5月3日修回。5月4日再次小修。5月8日正式录用。着急毕业的小伙伴们的不错选择。总体感觉高效、负责而且编辑特别友好，有问题可以随时邮件沟通。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=132, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/4NXDp7dcypiciaGCGMHhr89HtM35HDYiaaFxvhVe8OBZhvT0shhzj9TiczQwEA8xibW2Elb4XQciaB3hKL7aHww8g90w/0, createdBy=5af82170565, createdName=绿蚁红泥, createdTime=Wed Dec 18 00:00:00 CST 2019, time=2019-12-18, status=1, ipAttribution=)]

2022-11-07 含

WB需要全膜带Marker的原始数据吗

36 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2149996, encodeId=00be2149996b3, content=四天前发了邮件给编辑部，到现在都没回，我太难了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cb368660953, createdName=ms9000001976206462, createdTime=Wed Jul 26 20:27:40 CST 2023, time=2023-07-26, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1240251, encodeId=192c12402515c, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：分享一下经验，之前接受到杂志的约稿邮件，然后整理数据将文章投上去，投的是杂志特刊，做的是药物治疗疾病的研究和机制探讨，特别要表扬的是编辑，超级超级超级。。。Nice，真的是有问必回，而且特别高效。送了3个审稿人，然后经历过一次小修（5天时间要求修回），收到接收函的第二天proof和invoice就来了，proof要求24小时内提交，付款要求5天内完成。从投到接收不到1个月。因为是约稿，版面费还有优惠，所以该杂志值得投稿，良心杂志。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=8c811928827, createdName=1e0c52fcm39(暂无匿称), createdTime=Mon Aug 22 11:15:01 CST 2022, time=2022-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2117818, encodeId=e1e5211e818bf, content=伦理要求上传Patient Consent Form for Articles Containing Patient Details and/or Images。能否使用representative，Relationship of representative to patient这一部分怎么填啊？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a7475559954, createdName=ms1000001854041919, createdTime=Sun Mar 05 23:07:34 CST 2023, time=2023-03-05, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=915861, encodeId=048e9158618d, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：这杂志一审居然4个审稿人，3小修一拒，给了个大修！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=129, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/07/03/a49c0c976fe7f81b1448833c8538aa24.jpg, createdBy=cb9a1630518, createdName=Rtase, createdTime=Tue Jan 12 11:40:34 CST 2021, time=2021-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2098959, encodeId=afd520989595f, content=WB需要全膜带Marker的原始数据吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=2f0d2095817, createdName=含, createdTime=Mon Nov 07 13:16:41 CST 2022, time=2022-11-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1240378, encodeId=c9df12403e837, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：单体;动物疾病模型 经验分享：两个审稿人均要求疯狂补实验，要求很苛刻，大修两次，终于接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=01c92285047, createdName=361152897, createdTime=Mon Aug 22 22:27:34 CST 2022, time=2022-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2092279, encodeId=c6cd20922e9ed, content=审稿速度:1.0 经验分享：确实审稿特别快，两个星期就有相应的返修意见，历经2个星期返修，一天小修，就接受了，历经一个月，编辑对很多文章的逻辑问题还有其他小问题，都会提到，非常负责，非常感谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=93c45646864, createdName=ms8000000222715123, createdTime=Fri Oct 07 14:47:47 CST 2022, time=2022-10-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1232693, encodeId=05401232693bb, content=想问下拒收医院投稿是所有作者里都不能有作者单位是医院的吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=097b5528718, createdName=ms1000000533864290, createdTime=Fri Jul 15 22:23:33 CST 2022, time=2022-07-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1200156, encodeId=45aa120015642, content=偏重的研究方向：药理;中药 经验分享：想问一下我的under review一个月了，还没消息。不是说很快嘛？着急。可以催稿吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bc165513547, createdName=ms6000001633558853, createdTime=Mon Mar 07 09:16:08 CST 2022, time=2022-03-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=581730, encodeId=bb33581e302a, content=请问需要机构邮箱吗？自己的邮箱不行吗？130xyvn1159(暂无昵称) 2019-05-14 17:41:00 发表: 分享一下经验，效率非常高的杂志，我做的中药单体。4月2日投稿，4月15日编辑给的大修意见，限时10天。两个审稿人都非常负责，非常专业，给提的问题和建议也非常多，写了15页的response，最后一天修回。4月29日通知小修，5月3日修回。5月4日再次小修。5月8日正式录用。着急毕业的小伙伴们的不错选择。总体感觉高效、负责而且编辑特别友好，有问题可以随时邮件沟通。, beContent=130xyvn1159(暂无昵称) 2019-05-14 17:41:00 发表: 分享一下经验，效率非常高的杂志，我做的中药单体。4月2日投稿，4月15日编辑给的大修意见，限时10天。两个审稿人都非常负责，非常专业，给提的问题和建议也非常多，写了15页的response，最后一天修回。4月29日通知小修，5月3日修回。5月4日再次小修。5月8日正式录用。着急毕业的小伙伴们的不错选择。总体感觉高效、负责而且编辑特别友好，有问题可以随时邮件沟通。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=132, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/4NXDp7dcypiciaGCGMHhr89HtM35HDYiaaFxvhVe8OBZhvT0shhzj9TiczQwEA8xibW2Elb4XQciaB3hKL7aHww8g90w/0, createdBy=5af82170565, createdName=绿蚁红泥, createdTime=Wed Dec 18 00:00:00 CST 2019, time=2019-12-18, status=1, ipAttribution=)]

2022-08-22 361152897

审稿速度:2.0 | 投稿命中率:50.0
偏重的研究方向：单体;动物疾病模型
经验分享：两个审稿人均要求疯狂补实验，要求很苛刻，大修两次，终于接收。

48 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2149996, encodeId=00be2149996b3, content=四天前发了邮件给编辑部，到现在都没回，我太难了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cb368660953, createdName=ms9000001976206462, createdTime=Wed Jul 26 20:27:40 CST 2023, time=2023-07-26, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1240251, encodeId=192c12402515c, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：分享一下经验，之前接受到杂志的约稿邮件，然后整理数据将文章投上去，投的是杂志特刊，做的是药物治疗疾病的研究和机制探讨，特别要表扬的是编辑，超级超级超级。。。Nice，真的是有问必回，而且特别高效。送了3个审稿人，然后经历过一次小修（5天时间要求修回），收到接收函的第二天proof和invoice就来了，proof要求24小时内提交，付款要求5天内完成。从投到接收不到1个月。因为是约稿，版面费还有优惠，所以该杂志值得投稿，良心杂志。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=8c811928827, createdName=1e0c52fcm39(暂无匿称), createdTime=Mon Aug 22 11:15:01 CST 2022, time=2022-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2117818, encodeId=e1e5211e818bf, content=伦理要求上传Patient Consent Form for Articles Containing Patient Details and/or Images。能否使用representative，Relationship of representative to patient这一部分怎么填啊？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a7475559954, createdName=ms1000001854041919, createdTime=Sun Mar 05 23:07:34 CST 2023, time=2023-03-05, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=915861, encodeId=048e9158618d, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：这杂志一审居然4个审稿人，3小修一拒，给了个大修！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=129, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/07/03/a49c0c976fe7f81b1448833c8538aa24.jpg, createdBy=cb9a1630518, createdName=Rtase, createdTime=Tue Jan 12 11:40:34 CST 2021, time=2021-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2098959, encodeId=afd520989595f, content=WB需要全膜带Marker的原始数据吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=2f0d2095817, createdName=含, createdTime=Mon Nov 07 13:16:41 CST 2022, time=2022-11-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1240378, encodeId=c9df12403e837, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：单体;动物疾病模型 经验分享：两个审稿人均要求疯狂补实验，要求很苛刻，大修两次，终于接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=01c92285047, createdName=361152897, createdTime=Mon Aug 22 22:27:34 CST 2022, time=2022-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2092279, encodeId=c6cd20922e9ed, content=审稿速度:1.0 经验分享：确实审稿特别快，两个星期就有相应的返修意见，历经2个星期返修，一天小修，就接受了，历经一个月，编辑对很多文章的逻辑问题还有其他小问题，都会提到，非常负责，非常感谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=93c45646864, createdName=ms8000000222715123, createdTime=Fri Oct 07 14:47:47 CST 2022, time=2022-10-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1232693, encodeId=05401232693bb, content=想问下拒收医院投稿是所有作者里都不能有作者单位是医院的吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=097b5528718, createdName=ms1000000533864290, createdTime=Fri Jul 15 22:23:33 CST 2022, time=2022-07-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1200156, encodeId=45aa120015642, content=偏重的研究方向：药理;中药 经验分享：想问一下我的under review一个月了，还没消息。不是说很快嘛？着急。可以催稿吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bc165513547, createdName=ms6000001633558853, createdTime=Mon Mar 07 09:16:08 CST 2022, time=2022-03-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=581730, encodeId=bb33581e302a, content=请问需要机构邮箱吗？自己的邮箱不行吗？130xyvn1159(暂无昵称) 2019-05-14 17:41:00 发表: 分享一下经验，效率非常高的杂志，我做的中药单体。4月2日投稿，4月15日编辑给的大修意见，限时10天。两个审稿人都非常负责，非常专业，给提的问题和建议也非常多，写了15页的response，最后一天修回。4月29日通知小修，5月3日修回。5月4日再次小修。5月8日正式录用。着急毕业的小伙伴们的不错选择。总体感觉高效、负责而且编辑特别友好，有问题可以随时邮件沟通。, beContent=130xyvn1159(暂无昵称) 2019-05-14 17:41:00 发表: 分享一下经验，效率非常高的杂志，我做的中药单体。4月2日投稿，4月15日编辑给的大修意见，限时10天。两个审稿人都非常负责，非常专业，给提的问题和建议也非常多，写了15页的response，最后一天修回。4月29日通知小修，5月3日修回。5月4日再次小修。5月8日正式录用。着急毕业的小伙伴们的不错选择。总体感觉高效、负责而且编辑特别友好，有问题可以随时邮件沟通。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=132, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/4NXDp7dcypiciaGCGMHhr89HtM35HDYiaaFxvhVe8OBZhvT0shhzj9TiczQwEA8xibW2Elb4XQciaB3hKL7aHww8g90w/0, createdBy=5af82170565, createdName=绿蚁红泥, createdTime=Wed Dec 18 00:00:00 CST 2019, time=2019-12-18, status=1, ipAttribution=)]

2022-10-07 ms8000000222715123

审稿速度:1.0
经验分享：确实审稿特别快，两个星期就有相应的返修意见，历经2个星期返修，一天小修，就接受了，历经一个月，编辑对很多文章的逻辑问题还有其他小问题，都会提到，非常负责，非常感谢

48 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2149996, encodeId=00be2149996b3, content=四天前发了邮件给编辑部，到现在都没回，我太难了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cb368660953, createdName=ms9000001976206462, createdTime=Wed Jul 26 20:27:40 CST 2023, time=2023-07-26, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1240251, encodeId=192c12402515c, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：分享一下经验，之前接受到杂志的约稿邮件，然后整理数据将文章投上去，投的是杂志特刊，做的是药物治疗疾病的研究和机制探讨，特别要表扬的是编辑，超级超级超级。。。Nice，真的是有问必回，而且特别高效。送了3个审稿人，然后经历过一次小修（5天时间要求修回），收到接收函的第二天proof和invoice就来了，proof要求24小时内提交，付款要求5天内完成。从投到接收不到1个月。因为是约稿，版面费还有优惠，所以该杂志值得投稿，良心杂志。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=8c811928827, createdName=1e0c52fcm39(暂无匿称), createdTime=Mon Aug 22 11:15:01 CST 2022, time=2022-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2117818, encodeId=e1e5211e818bf, content=伦理要求上传Patient Consent Form for Articles Containing Patient Details and/or Images。能否使用representative，Relationship of representative to patient这一部分怎么填啊？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a7475559954, createdName=ms1000001854041919, createdTime=Sun Mar 05 23:07:34 CST 2023, time=2023-03-05, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=915861, encodeId=048e9158618d, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：这杂志一审居然4个审稿人，3小修一拒，给了个大修！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=129, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/07/03/a49c0c976fe7f81b1448833c8538aa24.jpg, createdBy=cb9a1630518, createdName=Rtase, createdTime=Tue Jan 12 11:40:34 CST 2021, time=2021-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2098959, encodeId=afd520989595f, content=WB需要全膜带Marker的原始数据吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=2f0d2095817, createdName=含, createdTime=Mon Nov 07 13:16:41 CST 2022, time=2022-11-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1240378, encodeId=c9df12403e837, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：单体;动物疾病模型 经验分享：两个审稿人均要求疯狂补实验，要求很苛刻，大修两次，终于接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=01c92285047, createdName=361152897, createdTime=Mon Aug 22 22:27:34 CST 2022, time=2022-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2092279, encodeId=c6cd20922e9ed, content=审稿速度:1.0 经验分享：确实审稿特别快，两个星期就有相应的返修意见，历经2个星期返修，一天小修，就接受了，历经一个月，编辑对很多文章的逻辑问题还有其他小问题，都会提到，非常负责，非常感谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=93c45646864, createdName=ms8000000222715123, createdTime=Fri Oct 07 14:47:47 CST 2022, time=2022-10-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1232693, encodeId=05401232693bb, content=想问下拒收医院投稿是所有作者里都不能有作者单位是医院的吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=097b5528718, createdName=ms1000000533864290, createdTime=Fri Jul 15 22:23:33 CST 2022, time=2022-07-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1200156, encodeId=45aa120015642, content=偏重的研究方向：药理;中药 经验分享：想问一下我的under review一个月了，还没消息。不是说很快嘛？着急。可以催稿吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bc165513547, createdName=ms6000001633558853, createdTime=Mon Mar 07 09:16:08 CST 2022, time=2022-03-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=581730, encodeId=bb33581e302a, content=请问需要机构邮箱吗？自己的邮箱不行吗？130xyvn1159(暂无昵称) 2019-05-14 17:41:00 发表: 分享一下经验，效率非常高的杂志，我做的中药单体。4月2日投稿，4月15日编辑给的大修意见，限时10天。两个审稿人都非常负责，非常专业，给提的问题和建议也非常多，写了15页的response，最后一天修回。4月29日通知小修，5月3日修回。5月4日再次小修。5月8日正式录用。着急毕业的小伙伴们的不错选择。总体感觉高效、负责而且编辑特别友好，有问题可以随时邮件沟通。, beContent=130xyvn1159(暂无昵称) 2019-05-14 17:41:00 发表: 分享一下经验，效率非常高的杂志，我做的中药单体。4月2日投稿，4月15日编辑给的大修意见，限时10天。两个审稿人都非常负责，非常专业，给提的问题和建议也非常多，写了15页的response，最后一天修回。4月29日通知小修，5月3日修回。5月4日再次小修。5月8日正式录用。着急毕业的小伙伴们的不错选择。总体感觉高效、负责而且编辑特别友好，有问题可以随时邮件沟通。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=132, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/4NXDp7dcypiciaGCGMHhr89HtM35HDYiaaFxvhVe8OBZhvT0shhzj9TiczQwEA8xibW2Elb4XQciaB3hKL7aHww8g90w/0, createdBy=5af82170565, createdName=绿蚁红泥, createdTime=Wed Dec 18 00:00:00 CST 2019, time=2019-12-18, status=1, ipAttribution=)]

2022-07-15 ms1000000533864290

想问下拒收医院投稿是所有作者里都不能有作者单位是医院的吗？

63 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=2149996, encodeId=00be2149996b3, content=四天前发了邮件给编辑部，到现在都没回，我太难了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cb368660953, createdName=ms9000001976206462, createdTime=Wed Jul 26 20:27:40 CST 2023, time=2023-07-26, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1240251, encodeId=192c12402515c, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：分享一下经验，之前接受到杂志的约稿邮件，然后整理数据将文章投上去，投的是杂志特刊，做的是药物治疗疾病的研究和机制探讨，特别要表扬的是编辑，超级超级超级。。。Nice，真的是有问必回，而且特别高效。送了3个审稿人，然后经历过一次小修（5天时间要求修回），收到接收函的第二天proof和invoice就来了，proof要求24小时内提交，付款要求5天内完成。从投到接收不到1个月。因为是约稿，版面费还有优惠，所以该杂志值得投稿，良心杂志。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=8c811928827, createdName=1e0c52fcm39(暂无匿称), createdTime=Mon Aug 22 11:15:01 CST 2022, time=2022-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2117818, encodeId=e1e5211e818bf, content=伦理要求上传Patient Consent Form for Articles Containing Patient Details and/or Images。能否使用representative，Relationship of representative to patient这一部分怎么填啊？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a7475559954, createdName=ms1000001854041919, createdTime=Sun Mar 05 23:07:34 CST 2023, time=2023-03-05, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=915861, encodeId=048e9158618d, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：这杂志一审居然4个审稿人，3小修一拒，给了个大修！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=129, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/07/03/a49c0c976fe7f81b1448833c8538aa24.jpg, createdBy=cb9a1630518, createdName=Rtase, createdTime=Tue Jan 12 11:40:34 CST 2021, time=2021-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2098959, encodeId=afd520989595f, content=WB需要全膜带Marker的原始数据吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=2f0d2095817, createdName=含, createdTime=Mon Nov 07 13:16:41 CST 2022, time=2022-11-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1240378, encodeId=c9df12403e837, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：单体;动物疾病模型 经验分享：两个审稿人均要求疯狂补实验，要求很苛刻，大修两次，终于接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=01c92285047, createdName=361152897, createdTime=Mon Aug 22 22:27:34 CST 2022, time=2022-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2092279, encodeId=c6cd20922e9ed, content=审稿速度:1.0 经验分享：确实审稿特别快，两个星期就有相应的返修意见，历经2个星期返修，一天小修，就接受了，历经一个月，编辑对很多文章的逻辑问题还有其他小问题，都会提到，非常负责，非常感谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=93c45646864, createdName=ms8000000222715123, createdTime=Fri Oct 07 14:47:47 CST 2022, time=2022-10-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1232693, encodeId=05401232693bb, content=想问下拒收医院投稿是所有作者里都不能有作者单位是医院的吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=097b5528718, createdName=ms1000000533864290, createdTime=Fri Jul 15 22:23:33 CST 2022, time=2022-07-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1200156, encodeId=45aa120015642, content=偏重的研究方向：药理;中药 经验分享：想问一下我的under review一个月了，还没消息。不是说很快嘛？着急。可以催稿吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bc165513547, createdName=ms6000001633558853, createdTime=Mon Mar 07 09:16:08 CST 2022, time=2022-03-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=581730, encodeId=bb33581e302a, content=请问需要机构邮箱吗？自己的邮箱不行吗？130xyvn1159(暂无昵称) 2019-05-14 17:41:00 发表: 分享一下经验，效率非常高的杂志，我做的中药单体。4月2日投稿，4月15日编辑给的大修意见，限时10天。两个审稿人都非常负责，非常专业，给提的问题和建议也非常多，写了15页的response，最后一天修回。4月29日通知小修，5月3日修回。5月4日再次小修。5月8日正式录用。着急毕业的小伙伴们的不错选择。总体感觉高效、负责而且编辑特别友好，有问题可以随时邮件沟通。, beContent=130xyvn1159(暂无昵称) 2019-05-14 17:41:00 发表: 分享一下经验，效率非常高的杂志，我做的中药单体。4月2日投稿，4月15日编辑给的大修意见，限时10天。两个审稿人都非常负责，非常专业，给提的问题和建议也非常多，写了15页的response，最后一天修回。4月29日通知小修，5月3日修回。5月4日再次小修。5月8日正式录用。着急毕业的小伙伴们的不错选择。总体感觉高效、负责而且编辑特别友好，有问题可以随时邮件沟通。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=132, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/4NXDp7dcypiciaGCGMHhr89HtM35HDYiaaFxvhVe8OBZhvT0shhzj9TiczQwEA8xibW2Elb4XQciaB3hKL7aHww8g90w/0, createdBy=5af82170565, createdName=绿蚁红泥, createdTime=Wed Dec 18 00:00:00 CST 2019, time=2019-12-18, status=1, ipAttribution=)]

2022-03-07 ms6000001633558853

偏重的研究方向：药理;中药
经验分享：想问一下我的under review一个月了，还没消息。不是说很快嘛？着急。可以催稿吗？

59 6

展开6条回复

[GetPortalCommentsPageByObjectIdResponse(id=2149996, encodeId=00be2149996b3, content=四天前发了邮件给编辑部，到现在都没回，我太难了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cb368660953, createdName=ms9000001976206462, createdTime=Wed Jul 26 20:27:40 CST 2023, time=2023-07-26, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1240251, encodeId=192c12402515c, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：分享一下经验，之前接受到杂志的约稿邮件，然后整理数据将文章投上去，投的是杂志特刊，做的是药物治疗疾病的研究和机制探讨，特别要表扬的是编辑，超级超级超级。。。Nice，真的是有问必回，而且特别高效。送了3个审稿人，然后经历过一次小修（5天时间要求修回），收到接收函的第二天proof和invoice就来了，proof要求24小时内提交，付款要求5天内完成。从投到接收不到1个月。因为是约稿，版面费还有优惠，所以该杂志值得投稿，良心杂志。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=8c811928827, createdName=1e0c52fcm39(暂无匿称), createdTime=Mon Aug 22 11:15:01 CST 2022, time=2022-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2117818, encodeId=e1e5211e818bf, content=伦理要求上传Patient Consent Form for Articles Containing Patient Details and/or Images。能否使用representative，Relationship of representative to patient这一部分怎么填啊？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a7475559954, createdName=ms1000001854041919, createdTime=Sun Mar 05 23:07:34 CST 2023, time=2023-03-05, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=915861, encodeId=048e9158618d, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：这杂志一审居然4个审稿人，3小修一拒，给了个大修！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=129, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/07/03/a49c0c976fe7f81b1448833c8538aa24.jpg, createdBy=cb9a1630518, createdName=Rtase, createdTime=Tue Jan 12 11:40:34 CST 2021, time=2021-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2098959, encodeId=afd520989595f, content=WB需要全膜带Marker的原始数据吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=2f0d2095817, createdName=含, createdTime=Mon Nov 07 13:16:41 CST 2022, time=2022-11-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1240378, encodeId=c9df12403e837, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：单体;动物疾病模型 经验分享：两个审稿人均要求疯狂补实验，要求很苛刻，大修两次，终于接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=01c92285047, createdName=361152897, createdTime=Mon Aug 22 22:27:34 CST 2022, time=2022-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2092279, encodeId=c6cd20922e9ed, content=审稿速度:1.0 经验分享：确实审稿特别快，两个星期就有相应的返修意见，历经2个星期返修，一天小修，就接受了，历经一个月，编辑对很多文章的逻辑问题还有其他小问题，都会提到，非常负责，非常感谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=93c45646864, createdName=ms8000000222715123, createdTime=Fri Oct 07 14:47:47 CST 2022, time=2022-10-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1232693, encodeId=05401232693bb, content=想问下拒收医院投稿是所有作者里都不能有作者单位是医院的吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=097b5528718, createdName=ms1000000533864290, createdTime=Fri Jul 15 22:23:33 CST 2022, time=2022-07-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1200156, encodeId=45aa120015642, content=偏重的研究方向：药理;中药 经验分享：想问一下我的under review一个月了，还没消息。不是说很快嘛？着急。可以催稿吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bc165513547, createdName=ms6000001633558853, createdTime=Mon Mar 07 09:16:08 CST 2022, time=2022-03-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=581730, encodeId=bb33581e302a, content=请问需要机构邮箱吗？自己的邮箱不行吗？130xyvn1159(暂无昵称) 2019-05-14 17:41:00 发表: 分享一下经验，效率非常高的杂志，我做的中药单体。4月2日投稿，4月15日编辑给的大修意见，限时10天。两个审稿人都非常负责，非常专业，给提的问题和建议也非常多，写了15页的response，最后一天修回。4月29日通知小修，5月3日修回。5月4日再次小修。5月8日正式录用。着急毕业的小伙伴们的不错选择。总体感觉高效、负责而且编辑特别友好，有问题可以随时邮件沟通。, beContent=130xyvn1159(暂无昵称) 2019-05-14 17:41:00 发表: 分享一下经验，效率非常高的杂志，我做的中药单体。4月2日投稿，4月15日编辑给的大修意见，限时10天。两个审稿人都非常负责，非常专业，给提的问题和建议也非常多，写了15页的response，最后一天修回。4月29日通知小修，5月3日修回。5月4日再次小修。5月8日正式录用。着急毕业的小伙伴们的不错选择。总体感觉高效、负责而且编辑特别友好，有问题可以随时邮件沟通。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=132, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/4NXDp7dcypiciaGCGMHhr89HtM35HDYiaaFxvhVe8OBZhvT0shhzj9TiczQwEA8xibW2Elb4XQciaB3hKL7aHww8g90w/0, createdBy=5af82170565, createdName=绿蚁红泥, createdTime=Wed Dec 18 00:00:00 CST 2019, time=2019-12-18, status=1, ipAttribution=)]

2019-12-18 绿蚁红泥

请问需要机构邮箱吗？自己的邮箱不行吗？130xyvn1159(暂无昵称) 2019-05-14 17:41:00 发表:
分享一下经验，效率非常高的杂志，我做的中药单体。4月2日投稿，4月15日编辑给的大修意见，限时10天。两个审稿人都非常负责，非常专业，给提的问题和建议也非常多，写了15页的response，最后一天修回。4月29日通知小修，5月3日修回。5月4日再次小修。5月8日正式录用。着急毕业的小伙伴们的不错选择。总体感觉高效、负责而且编辑特别友好，有问题可以随时邮件沟通。

130xyvn1159(暂无昵称) 2019-05-14 17:41:00 发表: 分享一下经验，效率非常高的杂志，我做的中药单体。4月2日投稿，4月15日编辑给的大修意见，限时10天。两个审稿人都非常负责，非常专业，给提的问题和建议也非常多，写了15页的response，最后一天修回。4月29日通知小修，5月3日修回。5月4日再次小修。5月8日正式录用。着急毕业的小伙伴们的不错选择。总体感觉高效、负责而且编辑特别友好，有问题可以随时邮件沟通。

132 2

展开2条回复

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务